World Investment Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.7K	Hold	10,444	–	–	﹤0.01%	1542
2025 Q4	$50.4K	Sell	10,444 -200	-2%	-$670	﹤0.01%	1452
2025 Q3	$21.4K	Sell	10,644 -11,000	-51%	-$10.6K	﹤0.01%	1231
2025 Q2	$13K	Hold	21,644	–	–	﹤0.01%	1126
2025 Q1	$5.84K	Sell	21,644 -8,040	-27%	-$2.67K	﹤0.01%	1047
2024 Q4	$15.4K	Sell	29,684 -3,000	-9%	-$7.32K	﹤0.01%	999
2024 Q3	$106K	Buy	32,684 +2,000	+7%	+$6.48K	﹤0.01%	887
2024 Q2	$92.1K	Hold	30,684	–	–	0.01%	612
2024 Q1	$143K	Buy	+30,684	New	+$148K	0.02%	386
2022 Q4	–	Sell	-12,700	Closed	-$470K	–	266
2022 Q3	$470K	Hold	12,700	–	–	0.11%	137
2022 Q2	$312K	Sell	12,700 -1,500	-11%	-$32.7K	0.07%	191
2022 Q1	$383K	Hold	14,200	–	–	0.08%	172
2021 Q4	$263K	Hold	14,200	–	–	0.06%	220
2021 Q3	$372K	Buy	14,200 +200	+1%	+$5.35K	0.08%	167
2021 Q2	$448K	Sell	14,000 -500	-3%	-$17.4K	0.1%	139
2021 Q1	$486K	Sell	14,500 -1,650	-10%	-$57.7K	0.12%	119
2020 Q4	$589K	Sell	16,150 -350	-2%	-$12K	0.15%	110
2020 Q3	$621K	Sell	16,500 -400	-2%	-$15.5K	0.21%	74
2020 Q2	$630K	Buy	16,900 +2,900	+21%	+$123K	0.22%	70
2020 Q1	$478K	Buy	14,000 +1,000	+8%	+$40.3K	0.22%	70
2019 Q4	$507K	Buy	+13,000	New	+$395K	0.2%	71